BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16124168)

  • 21. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
    Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence.
    Orr JM; Barnett JC; Leath CA
    Gynecol Oncol; 2011 Sep; 122(3):501-4. PubMed ID: 21714992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed.
    Morell ND; Taylor JR; Snyder RN; Ziel HK; Saltz A; Willie S
    Obstet Gynecol; 1982 Jul; 60(1):41-5. PubMed ID: 7088449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
    Miller RA; Waters LL; Mody DR; Tams KC
    Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
    Costa MJ; Kenny MB; Naib ZM
    Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Cervical Cancer Among Low-Risk Populations: Orthodox Jewish Women as a Model.
    Caspi R; Schejter E; Groutz A
    J Womens Health (Larchmt); 2016 Jul; 25(7):747-51. PubMed ID: 26599257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
    Levine PH; Elgert PA; Mittal K
    Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of endocervical cells in the diagnosis of cervical epithelial changes.
    Elias A; Linthorst G; Bekker B; Vooijs PG
    Acta Cytol; 1983; 27(3):225-9. PubMed ID: 6575534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
    Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
    Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
    Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
    Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
    Coleman DV; Poznansky JJ
    Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974.
    Dunn JE; Schweitzer V
    Am J Obstet Gynecol; 1981 Apr; 139(8):868-76. PubMed ID: 7223789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.